MET · Metlife Inc · Metrics
Market Cap
$61.67B
Shares
635.48M
MET metrics
68 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$95.92
Market cap
$61.67B
Price action
20 metricsPrice change (1W)
-2.3%
Price change (30D)
-0.3%
Price change (3M)
+9.0%
Price change (6M)
+37.2%
Price change (YTD)
+21.5%
Price change (1Y)
+18.4%
Trailing year
Price change (5Y)
+61.3%
52-week high
$99.95
52-week low
$67.70
Change from 52-week high
-4.0%
Change from 52-week low
+41.7%
Annualized volatility
23.6%
Annualized volatility (3M)
22.5%
Beta
0.7
RSI (14D)
47.9
Price vs SMA 50
-0.1%
Price vs SMA 200
+15.4%
Avg volume (3M)
3.42M
Relative volume
0.8
Average dollar volume
$322.29M
Company
3 metricsSector
Financial Services
Industry
Insurance - Life
Shares outstanding
635.48M
Valuation
12 metricsP / E (TTM)
18.5
Trailing earnings · reciprocal yield 5.4%
PEG ratio
3.2
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 128.8%
P / book
2.2
reciprocal yield 44.5%
FCF yield
—
TTM · current market cap
Buyback yield
4.0%
P / FCF
—
P / operating cash flow
4.0
reciprocal yield 25.2%
Earnings yield
5.9%
Historical valuation
8 metricsP / E historical average (3Y)
18.4×
reciprocal yield 5.4%
P / E historical average (5Y)
26.6×
reciprocal yield 3.8%
EV / revenue historical average (3Y)
0.6×
reciprocal yield 173.9%
EV / revenue historical average (5Y)
0.6×
reciprocal yield 173.8%
EV / EBIT historical average (3Y)
6.9×
reciprocal yield 14.5%
EV / EBIT historical average (5Y)
6.9×
reciprocal yield 14.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
41.6%
Shareholder yield
6.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
—
Operating margin
8.3%
Trailing 12 months
Net margin
4.6%
Gross profit (TTM)
—
Operating profit (TTM)
$6.56B
Net income (TTM)
$3.63B
Trailing 12 months
Diluted EPS (TTM)
$5.23
FCF margin
—
Effective tax rate
24.9%
Growth
11 metricsRevenue growth YoY
+10.5%
Year over year
Net income growth YoY
+1.0%
Revenue (TTM)
$79.40B
Trailing 12 months
EPS growth YoY
+5.8%
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+3.9%
Revenue CAGR (5Y)
+2.6%
EPS CAGR (3Y)
-9.2%
EPS CAGR (5Y)
-3.7%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
13.2%
Return on assets
0.5%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$19.30B
Total assets
$759.37B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$15.56B
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
1,458
13F filer change QoQ
+66
Institutional ownership
77.4%
Short interest
3 metricsShort interest
1.9%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
57 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1099219
CUSIP
59156R108
13F (30d)
26 filings
22 filers
Visit website
Investor relations